About Us
RAINs medical research and development is focused on serving the world with our innovative adjuvant technology to fight against antimicrobial resistance or SUPERBUGS, widely recognized as the largest threat to global health. Why RAIN? Rain is a blessing to the earth as it brings life to all that it touches and this is exactly what our technology will do as we complete scientific validation and regulatory processes in preparation to bring our product to market.
What we do...
RAIN Scientific is a biomedical engineering company focused on our platform technology that is an adjuvant to standard of care therapeutics. Our initial focus is to support the fight against SEPSIS and antimicrobial resistance...
Who we are...
A passionate and diverse group of professionals from both the medical and industrial sectors that have come together to launch this amazing technology, which once available, will make a significant impact on global health supporting the fight against some of the worst infectious diseases.
Who Is RAIN Scientific?
Research...
Rain Scientific Inc. is currently collaborating with leading research institutes focused on the fight against antimicrobial resistance (AMR) both by modulating the immune system and enhancing pathogen disruption. AMR is widely accepted as the largest threat to global health so we couldn't be more excited about the market we seek to serve.
Updates...
October 2021: RAIN has completed in vitro research which has shown solid efficacy against AMR pathogens. RAIN has successfully completed early safety trials leading to our upcoming GCP Human Safety trials. RAINs regulatory team has completed their regulatory review of our technology, its best possible application, which has led to a clearly defined regulatory path forward. RAIN continues to work with our research collaborators moving on toward advanced in vitro testing as well small animal in vivo trails. We are excited about the current state of RAIN and look forward to sharing more here as things continue to develop...